{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T23:12:33Z","timestamp":1790896353722,"version":"4.1.0"},"reference-count":51,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2008,3,1]],"date-time":"2008-03-01T00:00:00Z","timestamp":1204329600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Advanced Drug Delivery Reviews"],"published-print":{"date-parts":[[2008,3]]},"DOI":"10.1016\/j.addr.2007.08.042","type":"journal-article","created":{"date-parts":[[2007,12,4]],"date-time":"2007-12-04T09:18:19Z","timestamp":1196759899000},"page":"692-701","source":"Crossref","is-referenced-by-count":66,"title":["Enhancing drug absorption using lipids: A case study presenting the development and pharmacological evaluation of a novel lipid-based oral amphotericin B formulation for the treatment of systemic fungal infections"],"prefix":"10.1016","volume":"60","author":[{"given":"Kristina","family":"Sachs-Barrable","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen D.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen K.","family":"Wasan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheila J.","family":"Thornton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kishor M.","family":"Wasan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.addr.2007.08.042_bib1","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0035-9203(96)90271-0","article-title":"Comparison of three treatment regimens with liposomal amphotericin B (AmBisome) for visceral leishmaniasis in India: a randomized dose-finding study","volume":"90","author":"Thakur","year":"1996","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"10.1016\/j.addr.2007.08.042_bib2","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/j.1365-2710.1993.tb00605.x","article-title":"Amphotericin B and its delivery by liposomal and lipid formulations","volume":"18","author":"Gates","year":"1993","journal-title":"J. Clin. Pharm. Ther."},{"key":"10.1016\/j.addr.2007.08.042_bib3","doi-asserted-by":"crossref","first-page":"S154","DOI":"10.1093\/clinids\/14.Supplement_1.S154","article-title":"Current role of therapy with amphotericin B","volume":"14","author":"Meyer","year":"1992","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.addr.2007.08.042_bib4","doi-asserted-by":"crossref","first-page":"3339","DOI":"10.1128\/AAC.47.10.3339-3342.2003","article-title":"Effects of lipid-based oral formulations on plasma and tissue amphotericin B concentrations and renal toxicity in male rats","volume":"47","author":"Risovic","year":"2003","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.addr.2007.08.042_bib5","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1081\/DDC-120039793","article-title":"Potential mechanisms by which Peceol increases the gastrointestinal absorption of amphotericin B","volume":"30","author":"Risovic","year":"2004","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.addr.2007.08.042_bib6","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1080\/03639040601077349","article-title":"Assessing the antifungal activity of a new oral lipid-based amphotericin B formulation following administration to rats infected with Aspergillus fumigatus.","volume":"33","author":"Risovic","year":"2007","journal-title":"Drug Development and Industrial Pharmacy"},{"key":"10.1016\/j.addr.2007.08.042_bib7","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0169-409X(01)00151-X","article-title":"Intestinal lymphatic drug transport: an update","volume":"50","author":"Porter","year":"2001","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2007.08.042_bib8","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1124\/dmd.105.008102","article-title":"An examination of the interplay between enterocyte-based metabolism and lymphatic drug transport in the rat","volume":"34","author":"Trevaskis","year":"2006","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.addr.2007.08.042_bib9","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1159\/000136627","article-title":"The lymphocytic absorption of p,p\u2032-DDT and some structurally-related compounds in the rat","volume":"14","author":"Sieber","year":"1976","journal-title":"Pharmacology"},{"key":"10.1016\/j.addr.2007.08.042_bib10","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/nrd2197","article-title":"Lipids and lipid-based formulations: optimizing the oral delivery of drugs","volume":"6","author":"Porter","year":"2007","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.addr.2007.08.042_bib11","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/0378-5173(86)90027-X","article-title":"Estimating the maximal potential for intestinal lymphatic transport of lipophilic drug molecules","volume":"34","author":"Charman","year":"1986","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.addr.2007.08.042_bib12","doi-asserted-by":"crossref","first-page":"3146","DOI":"10.1128\/AAC.42.12.3146","article-title":"Pharmacokinetics, distribution in serum lipoproteins and tissues, and renal toxicities of amphotericin B and amphotericin B lipid complex in a hypercholesterolemic rabbit model: single-dose studies","volume":"42","author":"Wasan","year":"1998","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.addr.2007.08.042_bib13","doi-asserted-by":"crossref","first-page":"631","DOI":"10.3109\/03639049809082364","article-title":"Effect of various lipid bile salt mixed micelles on intestinal absorption of amphotericin B in rat","volume":"24","author":"Dangi","year":"1998","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.addr.2007.08.042_bib14","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1093\/jac\/36.1.119","article-title":"Structure and toxicity of amphotericin B\/triglyceride emulsion formulations","volume":"36","author":"Lance","year":"1995","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.addr.2007.08.042_bib15","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0940-2993(00)80115-3","article-title":"Lipid emulsion reduces subacute toxicity of amphotericin B: a histopathological study","volume":"52","author":"Souza","year":"2000","journal-title":"Exp. Toxicol. Pathol."},{"key":"10.1016\/j.addr.2007.08.042_bib16","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/S0006-2952(02)01558-7","article-title":"Minimally modified phosphodiester antisense oligodeoxyribonucleotide directed against the multidrug resistance gene mdr1","volume":"65","author":"Brigui","year":"2003","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.addr.2007.08.042_bib17","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1089\/mdr.1998.4.143","article-title":"In vivo characterization of the drug resistance profile of the major ABC transporters and other components of the yeast pleiotropic drug resistance network","volume":"4","author":"Kolaczkowski","year":"1998","journal-title":"Microb. Drug Resist.-Mechanisms Epidemiology and Disease"},{"key":"10.1016\/j.addr.2007.08.042_bib18","first-page":"1482","volume":"47","author":"White","year":"2003","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.addr.2007.08.042_bib19","series-title":"Physiology of the GastroIntestinal Tract","first-page":"1909","article-title":"Cellular and molecular mechanisms of small intestinal lipid transport","author":"Davidson","year":"1994"},{"key":"10.1016\/j.addr.2007.08.042_bib20","series-title":"Lipid Absorption: Biochemical and Clinical Aspects","first-page":"85","article-title":"Triglyceride biosynthesis in the intestinal mucosa","author":"Johnson","year":"1976"},{"key":"10.1016\/j.addr.2007.08.042_bib21","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1172\/JCI105267","article-title":"The composition and structure of lymph chylomicrons in dog, rat, and man","volume":"44","author":"Zilversmit","year":"1965","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.addr.2007.08.042_bib22","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1113\/expphysiol.1987.sp003059","article-title":"Partitioning of polar fatty acids into lymph and portal vein after intestinal absorption in the rat","volume":"72","author":"McDonald","year":"1987","journal-title":"Q.J. Exp. Physiol."},{"key":"10.1016\/j.addr.2007.08.042_bib23","first-page":"43","article-title":"Physico-chemical state of lipids in intestinal content during their digestion and absorption","volume":"21","author":"Hofmann","year":"1962","journal-title":"Fed. Proc."},{"key":"10.1016\/j.addr.2007.08.042_bib24","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/0378-5173(91)90221-9","volume":"69","author":"White","year":"1991","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.addr.2007.08.042_bib25","first-page":"G141","article-title":"Portal venous transport of long-chain fatty acids absorbed from rat intestine","volume":"239","author":"McDonald","year":"1980","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.addr.2007.08.042_bib26","first-page":"197","article-title":"Role of intestinal hydrolases, endogenous substrates and chyloportal partition in fat absorption","volume":"vol. 1","author":"Bugaut","year":"1987"},{"key":"10.1016\/j.addr.2007.08.042_bib27","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.vascn.2003.11.004","article-title":"A stepwise surgical procedure to investigate the lymphatic transport of lipid-based oral drug formulations: cannulation of the mesenteric and thoracic lymph ducts within the rat","volume":"49","author":"Boyd","year":"2004","journal-title":"J. Pharmacol. Toxicol. Methods"},{"key":"10.1016\/j.addr.2007.08.042_bib28","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1021\/js970300n","article-title":"Lipid-based delivery systems for improving the bioavailability and lymphatic transport of a poorly water-soluble LTB4 inhibitor","volume":"87","author":"Hauss","year":"1998","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.addr.2007.08.042_bib29","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ejps.2003.07.003","article-title":"The ABCs of drug transport in intestine and liver: efflux proteins limiting drug absorption and bioavailability","volume":"21","author":"Chan","year":"2004","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.addr.2007.08.042_bib30","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/0092-8674(86)90595-7","article-title":"Internal duplication and homology with bacterial transport proteins in the mdr1 (P-glycoprotein) gene from multidrug-resistant human cells","volume":"47","author":"Chen","year":"1986","journal-title":"Cell"},{"key":"10.1016\/j.addr.2007.08.042_bib31","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/0005-2736(76)90160-7","article-title":"A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants","volume":"455","author":"Juliano","year":"1976","journal-title":"Biochim. Biophys Acta"},{"key":"10.1016\/j.addr.2007.08.042_bib32","doi-asserted-by":"crossref","first-page":"4538","DOI":"10.1073\/pnas.83.12.4538","article-title":"Isolation of human mdr DNA sequences amplified in multidrug-resistant KB carcinoma cells","volume":"83","author":"Roninson","year":"1986","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.addr.2007.08.042_bib33","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/S0306-3623(96)00081-X","article-title":"The P-glycoprotein multidrug transporter","volume":"27","author":"Fardel","year":"1996","journal-title":"Gen. Pharmacol."},{"key":"10.1016\/j.addr.2007.08.042_bib34","doi-asserted-by":"crossref","first-page":"241","DOI":"10.2174\/1381612003401163","article-title":"What is the precise role of human MDR 1 protein in chemotherapeutic drug resistance?","volume":"6","author":"Roepe","year":"2000","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.addr.2007.08.042_bib35","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0168-3659(99)00036-X","article-title":"Kinetic and biochemical analysis of carrier-mediated efflux of drugs through the blood\u2013brain and blood\u2013cerebrospinal fluid barriers: importance in the drug delivery to the brain","volume":"62","author":"Sugiyama","year":"1999","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2007.08.042_bib36","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1023\/A:1007521430236","article-title":"Mechanisms of altered sequestration and efflux of chemotherapeutic drugs by multidrug-resistant cells","volume":"15","author":"Ouar","year":"1999","journal-title":"Cell Biol. Toxicol."},{"key":"10.1016\/j.addr.2007.08.042_bib37","first-page":"3109","article-title":"Multiple recognition of various amphiphilic molecules by the multidrug resistance P-glycoprotein: molecular mechanisms and pharmacological consequences coming from functional interactions between various drugs","volume":"19","author":"Orlowski","year":"1999","journal-title":"Anticancer Res."},{"key":"10.1016\/j.addr.2007.08.042_bib38","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/0925-4439(92)90131-6","article-title":"P-glycoprotein as multidrug transporter: a critical review of current multidrug resistant cell lines","volume":"1139","author":"Nielsen","year":"1992","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.addr.2007.08.042_bib39","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1002\/(SICI)1097-0215(19961009)68:2<245::AID-IJC18>3.0.CO;2-9","article-title":"Inhibition of cytarabine-induced MDR1 (P-glycoprotein) gene activation in human tumor cells by fatty acid-polyethylene glycol-fatty acid diesters, novel inhibitors of P-glycoprotein function","volume":"68","author":"Komarov","year":"1996","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.addr.2007.08.042_bib40","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/S0006-2952(99)00377-9","article-title":"Effects of sodium deoxycholate and sodium caprate on the transport of epirubicin in human intestinal epithelial Caco-2 cell layers and everted gut sacs of rats","volume":"59","author":"Lo","year":"2000","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.addr.2007.08.042_bib41","doi-asserted-by":"crossref","first-page":"25388","DOI":"10.1074\/jbc.270.43.25388","article-title":"Enhancement of Mdr2-mediated phosphatidylcholine translocation by the bile salt taurocholate. Implications for hepatic bile formation","volume":"270","author":"Ruetz","year":"1995","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.addr.2007.08.042_bib42","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1023\/A:1018942823676","article-title":"Fundamental relationships between the composition of pluronic block copolymers and their hypersensitization effect in MDR cancer cells","volume":"16","author":"Batrakova","year":"1999","journal-title":"Pharm. Res."},{"key":"10.1016\/j.addr.2007.08.042_bib43","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1023\/A:1018873702411","article-title":"Inhibition of multidrug resistance-associated protein (MRP) functional activity with pluronic block copolymers","volume":"16","author":"Miller","year":"1999","journal-title":"Pharm. Res."},{"key":"10.1016\/j.addr.2007.08.042_bib44","first-page":"5994","article-title":"Effects of nonionic detergents on P-glycoprotein drug binding and reversal of multidrug resistance","volume":"53","author":"Zordan-Nudo","year":"1993","journal-title":"Cancer Res."},{"key":"10.1016\/j.addr.2007.08.042_bib45","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1023\/A:1018990706838","article-title":"Pluronic P85 increases permeability of a broad spectrum of drugs in polarized BBMEC and Caco-2 cell monolayers","volume":"16","author":"Batrakova","year":"1999","journal-title":"Pharm. Res."},{"key":"10.1016\/j.addr.2007.08.042_bib46","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1046\/j.1432-1327.1999.00037.x","article-title":"Membrane fluidization by ether, other anesthetics, and certain agents abolishes P-glycoprotein ATPase activity and modulates efflux from multidrug-resistant cells","volume":"259","author":"Regev","year":"1999","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.addr.2007.08.042_bib47","first-page":"350","article-title":"Lipid excipients Peceol\u00ae and Gelucire\u00ae 44\/14 decrease P-glycoprotein mediated efflux of Rhodamine 123 partially due to modifying P-glycoprotein protein expression within Caco-2 cells","volume":"10","author":"Sachs-Barrable","year":"2007","journal-title":"J. Pharm. Pharm. Sci."},{"key":"10.1016\/j.addr.2007.08.042_bib48","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1093\/jac\/32.1.123","article-title":"In-vitro and in-vivo studies of the decrease of amphotericin B toxicity upon association with a triglyceride-rich emulsion","volume":"32","author":"Souza","year":"1993","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.addr.2007.08.042_bib49","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1023\/A:1015939307478","article-title":"In vivo model for ciclosporin intestinal absorption in lipid vehicles","volume":"5","author":"Reymond","year":"1988","journal-title":"Pharm. Res."},{"issue":"8","key":"10.1016\/j.addr.2007.08.042_bib50","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/S1473-3099(02)00347-X","article-title":"Visceral leishmaniasis: current status of control, diagnosis, and treatment, and a proposed research and development agenda","volume":"2","author":"Guerin","year":"2002","journal-title":"Lancet Infect. Dis."},{"issue":"6","key":"10.1016\/j.addr.2007.08.042_bib51","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1097\/00001432-200212000-00007","article-title":"Advances in the treatment of leishmaniasis","volume":"15","author":"Sundar","year":"2002","journal-title":"Curr. Opin. Infect. Dis."}],"container-title":["Advanced Drug Delivery Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169409X07003146?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169409X07003146?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,5]],"date-time":"2019-05-05T10:20:06Z","timestamp":1557051606000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169409X07003146"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,3]]},"references-count":51,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2008,3]]}},"alternative-id":["S0169409X07003146"],"URL":"https:\/\/doi.org\/10.1016\/j.addr.2007.08.042","relation":{},"ISSN":["0169-409X"],"issn-type":[{"value":"0169-409X","type":"print"}],"subject":[],"published":{"date-parts":[[2008,3]]}}}